Womaplat 150mg Injection
Marketer
Parenteral Drugs India Ltd
Salt Composition
Carboplatin (150mg)
Overview Womaplat 150mg Injection
Oncaspar 150mg Injection is indicated for ovarian and small cell lung cancers. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined individually by your physician, depending on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdosage can lead to severe adverse events. While therapeutic effects might not be apparent immediately, discontinue use only upon medical advice. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts (red and white blood cells), increasing infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine to your doctor. Regular blood tests are necessary to monitor blood cell levels, alongside heart, liver function, and uric acid. Report any allergic reactions like rash, itching, or breathing difficulties. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is essential throughout treatment to prevent conception.
Primary Ingredients of Womaplat 150mg Injection
No text provided to rephrase.
Uses of Womaplat 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Womaplat 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Womaplat 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Womaplat 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Womaplat 150mg Injection works:
Oncaspare injection (150mg) is a chemotherapeutic agent that disrupts the genetic composition (DNA and RNA) of malignant cells, thus inhibiting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Womaplat 150mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Womaplat 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Womaplat 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Womaplat 150mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from driving if such effects manifest.
KidneyCAUTION
Administering Womaplat 150mg Injection to individuals with kidney impairment requires careful consideration. A modified dosage of Womaplat 150mg Injection might be necessary. Physician consultation is recommended. Womaplat 150mg Injection is contraindicated in patients exhibiting severe kidney dysfunction. Routine monitoring of renal function is advisable during treatment.
LiverSAFE IF PRESCRIBED
The use of Womaplat 150mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Womaplat 150mg Injection :
Omitting a scheduled Womaplat 150mg Injection requires contacting your physician.
Facts to Know About Womaplat 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Platinum-Based Anticancer Agents |
3,018 People bought this recently